FinDogFinDog
Friday, October 30, 2026Closing data · 4:00 PM ET
English
Log in

IQV

IQVIANYSE · Life Sciences Tools & Services · Health Care
Previous close
267.33
Change
−7.73 / −2.81%
FinDog View
Bullish
52-Week Range ?
154.50 – 284.50
P/E (TTM) ?
32.4
Forward P/E ?
20.5
Based on consensus earnings for the next 12 months
Market Cap
$43.7B
1M
−0.57%
S&P 500 −0.91% over same period
Volume / Avg Volume
1.2M / 1.5M
0.75× average
Latest earnings analysisFY2026 Q2Reported 2026-07-28

IQVIA Q2 FY2026: revenue up 8.7%, bookings up 19%, guidance raised

IQVIA beat on adjusted earnings, grew revenue 8.7% and raised full-year revenue guidance, so the operational quarter reads Bullish even as GAAP profit slipped. The trick is reading it in two layers: the adjusted numbers and bookings show acceleration, while the GAAP statement shows restructuring, purchase-accounting amortization and interest eating the reported bottom line.

Read the full analysis →
Revenue$4.37BYoY +8.70%
EPS (non-GAAP)$3.15Beatest. $3.06
Next-quarter revenue guidance$17.38B ±0.6%YoY +297.80%
Next-day move+1.90%

Price History

Closing price · USD1M6M1Y5Y
150200250300EFY26 Q2 EarningsEFY26 Q1 EarningsEFY25 Q4 Earnings2025-102026-012026-052026-082026-10

Historical P/E

Close ÷ trailing four-quarter EPS · Period median 29.51M6M1Y5Y
202530352025-102026-012026-052026-082026-10

Recent Earnings

Click to read the FinDog analysis
PeriodReportedRevenueEPS Actual / Est.Next-Day MoveAnalysis

Next Earnings

Date and consensus from the earnings calendar; the analysis is generated automatically after the releaseEarnings Calendar →
Report date
2027-02-03
in 94 days · After hours
Consensus EPS
$3.68
Last quarter EPS $3.15
Avg. next-day move over the last 6 reports
±2.4%

Decision Panel

Trends · Valuation · Earnings reaction · Guidance credibility — all from company filings and market data
Valuation
P/E is at percentile 68 of its 5-year rangeMid-range
5-year range 20.5 – 38.6 · Median 30.4
Last 4 quarters: $1.2B in buybacks + $0 in dividends, 2.66% of market cap combined
P/E (TTM)
32.4
P/B
6.8
P/S
2.6
PEG
2.61
Earnings Reaction
Over the last 6 reports, the stock moved ±2.4% on average on the first trading day after, rising 5 times
Most recent +1.90%
Volatility & Correlation
1-year beta 0.74 · Correlation with S&P 500 0.24Tracks the market
Annualized volatility 40% vs. 13% for the S&P 500
Insider Trading
View all →
Last 90 days · Open-market buys and sells by officers and directors · Amounts in USD millions
Buy 0 · $0.00MSell 3 · $2.4MNet selling $2.4M
  • 09-02Berkshire James G.See RemarksSell$0.70M2,668 shares · Avg price 261.33
  • 08-03STAUB W RICHARDSee RemarksSell$1.3M5,500 shares · Avg price 232.68
  • 07-31Patel BhavikSee RemarksSell$0.44M1,855 shares · Avg price 235.27
Multi-Quarter Financial Trends
View all quarters →
Last 12 quarters · As reported by the company
QuarterRevenue ($B)YoYGross MarginOperating Income ($B)Net Income ($B)Free Cash Flow ($B)EPS
FY2026 Q34.43+8.0%—0.570.350.832.10
FY2026 Q24.37+8.7%—0.510.260.561.53
FY2026 Q14.15+8.4%—0.510.270.621.61
FY2025 Q44.36+10.3%—0.630.510.742.97
FY2025 Q34.10+5.2%—0.550.330.911.93
FY2025 Q24.02+5.3%—0.510.270.441.54
FY2025 Q13.83+2.5%—0.500.250.571.40
FY2024 Q43.96+2.3%—0.630.440.892.41
FY2024 Q33.90+4.3%—0.550.290.721.55
FY2024 Q23.81+2.3%—0.520.360.591.97
FY2024 Q13.74+2.3%—0.510.290.521.56
FY2023 Q43.87+3.5%—0.500.470.752.54

Peers

Largest by market cap in the sector · Latest quarterView Health Care sector →
TickerCompanyMarket CapP/ERevenue YoYGross Margin1MView